Professor AJ Thompson, Institute of Neurology, Queen Square, London WC1N 3BG, UK. Telephone 0044 171 837 3611 ext 4152; fax 0044 171 813 6505; email athompson{at}ion.ucl.ac.uk BACKGROUND The ...
2 Queen Square MS Centre, Institute of Neurology, University College London, London, UK Correspondence to Dr Todd Hardy, Box 21, National Hospital for Neurology and Neurosurgery, Queen Square, London ...
3 Division of Clinical Neurosciences, University of Edinburgh, Edinburgh, UK Correspondence to Professor Rustam Al-Shahi Salman, Division of Clinical Neurosciences, University of Edinburgh, Western ...
Methods The MEDLINE, Embase, Cochrane Central Register of Controlled Trials, PsycINFO, ClinicalTrials.gov and the WHO’s International Clinical Trials Registry Platform search portal were searched from ...
Background: In vivo evaluation of cholinergic circuits of the human brain has recently been introduced using a transcranial magnetic stimulation (TMS) protocol based on coupling peripheral nerve ...
4 Institute for Neuroimmunology and Clinical MS Research, Center for Molecular Neurobiology Hamburg (ZMNH), University Medical Center Eppendorf, Hamburg, Germany Correspondence to Dr Carsten Finke, ...
1 Department of Neurology, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands 2 Department of Epidemiology and Biostatistics, Radboud University Nijmegen Medical Centre, Nijmegen, ...
OBJECTIVES To investigate the factor structure and psychometric properties of the neurobehavioural rating scale-revised (NRS-R) and to determine its usefulness in clinical trials. METHODS A ...
Background: The 39 item Parkinson’s disease questionnaire (PDQ-39) is the most widely used patient reported rating scale in Parkinson’s disease. However, several fundamental measurement assumptions ...
1 Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands Correspondence to Professor Catharina J M Klijn, Department of ...
From 1979-85, 2435 patients with a transient ischaemic attack or minor ischaemic stroke were randomly allocated to receive long term "blind" treatment with aspirin 600 mg twice daily (n = 815), ...
Background Whether progression independent of relapse activity (PIRA) heralds earlier onset of secondary progressive multiple sclerosis (SPMS) and more rapid accumulation of disability during SPMS ...